Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

EPA:ALSOG - FR0000065864 - Common Stock

24 EUR
-0.2 (-0.83%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

6

Overall ALSOG gets a fundamental rating of 6 out of 10. We evaluated ALSOG against 43 industry peers in the Aerospace & Defense industry. ALSOG has only an average score on both its financial health and profitability. ALSOG scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, ALSOG could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

ALSOG had positive earnings in the past year.
In the past year ALSOG had a positive cash flow from operations.
Of the past 5 years ALSOG 4 years were profitable.
ALSOG had a positive operating cash flow in each of the past 5 years.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALSOG has a Return On Assets (2.90%) which is in line with its industry peers.
ALSOG has a Return On Equity (9.03%) which is in line with its industry peers.
ALSOG's Return On Invested Capital of 7.14% is in line compared to the rest of the industry. ALSOG outperforms 51.16% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALSOG is below the industry average of 9.49%.
The 3 year average ROIC (6.22%) for ALSOG is below the current ROIC(7.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.9%
ROE 9.03%
ROIC 7.14%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

ALSOG has a Profit Margin of 2.82%. This is comparable to the rest of the industry: ALSOG outperforms 41.86% of its industry peers.
In the last couple of years the Profit Margin of ALSOG has grown nicely.
ALSOG's Operating Margin of 4.65% is on the low side compared to the rest of the industry. ALSOG is outperformed by 67.44% of its industry peers.
In the last couple of years the Operating Margin of ALSOG has grown nicely.
The Gross Margin of ALSOG (56.71%) is better than 86.05% of its industry peers.
In the last couple of years the Gross Margin of ALSOG has remained more or less at the same level.
Industry RankSector Rank
OM 4.65%
PM (TTM) 2.82%
GM 56.71%
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

6

2. Health

2.1 Basic Checks

ALSOG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALSOG remains at a similar level compared to 1 year ago.
The debt/assets ratio for ALSOG has been reduced compared to a year ago.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

ALSOG has an Altman-Z score of 2.32. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
ALSOG's Altman-Z score of 2.32 is on the low side compared to the rest of the industry. ALSOG is outperformed by 62.79% of its industry peers.
The Debt to FCF ratio of ALSOG is 1.82, which is an excellent value as it means it would take ALSOG, only 1.82 years of fcf income to pay off all of its debts.
ALSOG has a better Debt to FCF ratio (1.82) than 83.72% of its industry peers.
ALSOG has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
ALSOG has a better Debt to Equity ratio (0.44) than 67.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.82
Altman-Z 2.32
ROIC/WACC0.98
WACC7.3%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.69 indicates that ALSOG should not have too much problems paying its short term obligations.
ALSOG's Current ratio of 1.69 is fine compared to the rest of the industry. ALSOG outperforms 79.07% of its industry peers.
A Quick Ratio of 1.44 indicates that ALSOG should not have too much problems paying its short term obligations.
ALSOG's Quick ratio of 1.44 is amongst the best of the industry. ALSOG outperforms 86.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.44
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

ALSOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.56%, which is quite impressive.
ALSOG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.82% yearly.
Looking at the last year, ALSOG shows a small growth in Revenue. The Revenue has grown by 6.07% in the last year.
The Revenue has been growing by 9.06% on average over the past years. This is quite good.
EPS 1Y (TTM)42.56%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%41.91%
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%

3.2 Future

The Earnings Per Share is expected to grow by 18.42% on average over the next years. This is quite good.
ALSOG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.01% yearly.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.55, ALSOG is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 95.35% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALSOG to the average of the S&P500 Index (27.03), we can say ALSOG is valued slightly cheaper.
With a Price/Forward Earnings ratio of 10.45, the valuation of ALSOG can be described as very reasonable.
ALSOG's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALSOG is cheaper than 97.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. ALSOG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.55
Fwd PE 10.45
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

97.67% of the companies in the same industry are more expensive than ALSOG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALSOG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.02
EV/EBITDA 7.88
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ALSOG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSOG has a very decent profitability rating, which may justify a higher PE ratio.
ALSOG's earnings are expected to grow with 18.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.76%, ALSOG has a reasonable but not impressive dividend return.
ALSOG's Dividend Yield is rather good when compared to the industry average which is at 1.25. ALSOG pays more dividend than 100.00% of the companies in the same industry.
ALSOG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.76%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

64.84% of the earnings are spent on dividend by ALSOG. This is not a sustainable payout ratio.
DP64.84%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (9/4/2025, 7:00:00 PM)

24

-0.2 (-0.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-30 2025-04-30
Earnings (Next)09-10 2025-09-10
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap76.80M
Analysts86.67
Price Target28.05 (16.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.76%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP64.84%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.55
Fwd PE 10.45
P/S 0.49
P/FCF 5.02
P/OCF 4.51
P/B 1.57
P/tB 2.94
EV/EBITDA 7.88
EPS(TTM)1.45
EY6.04%
EPS(NY)2.3
Fwd EY9.57%
FCF(TTM)4.78
FCFY19.92%
OCF(TTM)5.32
OCFY22.18%
SpS49.07
BVpS15.31
TBVpS8.15
PEG (NY)0.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.9%
ROE 9.03%
ROCE 8.19%
ROIC 7.14%
ROICexc 9.23%
ROICexgc 13.76%
OM 4.65%
PM (TTM) 2.82%
GM 56.71%
FCFM 9.74%
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexcg growth 3Y2.87%
ROICexcg growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.82
Debt/EBITDA 2.03
Cap/Depr 51.95%
Cap/Sales 1.11%
Interest Coverage 7.47
Cash Conversion 160%
Profit Quality 345.65%
Current Ratio 1.69
Quick Ratio 1.44
Altman-Z 2.32
F-Score8
WACC7.3%
ROIC/WACC0.98
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.56%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%41.91%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y3.84%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y289.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y203.6%
OCF growth 3Y101.39%
OCF growth 5YN/A